← Leaderboards
Douglas James Digirolamo
Johns Hopkins University
$2,003,410
Attributed
$2,003,410
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $534K · FY2011–15$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,003,410 · 1
By mechanism
R01$2,003,410 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Se-Jin Lee$17,681,857
- Mehran Armand$9,641,501
- Kathryn R Wagner$3,584,253
- Drew M. Pardoll$27,059,898
- Xu Cao$21,394,088
Others in their field
Top investigators on “Receptor Signaling”
- James C. Paulson · Scripps Research Institute$79,908,251
- Asrar B. Malik · University Of Illinois At Chicago$59,478,596
- Paul S. Aisen · Cognition Therapeutics, Inc.$49,774,251
- Joel S. Bennett · University Of Pennsylvania$49,566,593
- Bert W O'Malley · Baylor College Of Medicine$42,934,573
- Robert J Coffey · Vanderbilt University$38,345,366
Research focus
Receptor SignalingBiologyMusculoskeletal DiseasesPathway InteractionsSkeletal Muscle StructureCollaborationsMouse ModelMuscle FormMyostatinOsteoblastsSignal PathwayBoneTissuesAcvr2b GeneBone MassAcvr2 GeneBaseMuscleActivin ReceptorGeneticInterestAge RelatedIntraperitoneal InjectionsGrowth
Grant awards (6)
Activin receptor-based therapies for musculoskeletal disease$368,352
R01 · FY2015 · AR · contact PI
Activin receptor-based therapies for musculoskeletal disease$360,984
R01 · FY2014 · AR · contact PI
Activin receptor-based therapies for musculoskeletal disease$173,036
R01 · FY2014 · AR · contact PI
Activin receptor-based therapies for musculoskeletal disease$349,934
R01 · FY2013 · AR · contact PI
Activin receptor-based therapies for musculoskeletal disease$368,352
R01 · FY2012 · AR · contact PI
Activin receptor-based therapies for musculoskeletal disease$382,752
R01 · FY2011 · AR · contact PI